Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CADL |
---|---|---|
09:32 ET | 9747 | 12.9 |
09:34 ET | 7958 | 12.76 |
09:36 ET | 18758 | 12.505 |
09:38 ET | 25812 | 12.42 |
09:39 ET | 12846 | 12.61 |
09:41 ET | 8780 | 12.68 |
09:43 ET | 5579 | 12.8608 |
09:45 ET | 6600 | 12.8 |
09:48 ET | 3663 | 12.92 |
09:50 ET | 2988 | 12.8 |
09:52 ET | 2500 | 12.76 |
09:56 ET | 500 | 12.78 |
09:57 ET | 1500 | 12.735 |
09:59 ET | 400 | 12.7 |
10:01 ET | 4827 | 12.5 |
10:03 ET | 13345 | 12.52 |
10:06 ET | 1681 | 12.5083 |
10:08 ET | 1201 | 12.545 |
10:10 ET | 4646 | 12.68 |
10:12 ET | 200 | 12.68 |
10:14 ET | 1574 | 12.64 |
10:15 ET | 1000 | 12.6719 |
10:17 ET | 1321 | 12.6964 |
10:19 ET | 6147 | 12.5509 |
10:21 ET | 396 | 12.5302 |
10:26 ET | 855 | 12.5535 |
10:28 ET | 1292 | 12.5 |
10:30 ET | 8634 | 12.5526 |
10:32 ET | 3580 | 12.375 |
10:33 ET | 1986 | 12.4482 |
10:35 ET | 2624 | 12.4001 |
10:37 ET | 2607 | 12.5 |
10:39 ET | 786 | 12.6 |
10:42 ET | 200 | 12.6 |
10:44 ET | 1000 | 12.61 |
10:46 ET | 915 | 12.54 |
10:48 ET | 4711 | 12.6439 |
10:50 ET | 3500 | 12.6799 |
10:51 ET | 3628 | 12.58 |
10:53 ET | 2640 | 12.5 |
10:55 ET | 994 | 12.43 |
10:57 ET | 8489 | 12.49 |
11:00 ET | 950 | 12.52 |
11:02 ET | 8010 | 12.4 |
11:04 ET | 4480 | 12.39 |
11:06 ET | 2714 | 12.41 |
11:08 ET | 848 | 12.4101 |
11:09 ET | 2500 | 12.4313 |
11:11 ET | 1909 | 12.35 |
11:13 ET | 12103 | 12.1425 |
11:15 ET | 89769 | 11.84 |
11:18 ET | 10656 | 11.73 |
11:20 ET | 5830 | 11.87 |
11:22 ET | 2374 | 11.8817 |
11:24 ET | 2669 | 12.08 |
11:26 ET | 4550 | 12.06 |
11:27 ET | 4281 | 12.045 |
11:29 ET | 3232 | 12.04 |
11:31 ET | 2376 | 11.9999 |
11:33 ET | 1800 | 12.12 |
11:36 ET | 2425 | 12.1899 |
11:38 ET | 5472 | 12.2 |
11:40 ET | 2218 | 12.21 |
11:42 ET | 1007 | 12.209 |
11:44 ET | 1600 | 12.14 |
11:47 ET | 2670 | 12.05 |
11:49 ET | 2856 | 12.08 |
11:51 ET | 1400 | 12.0687 |
11:54 ET | 350 | 12.0672 |
11:56 ET | 1395 | 12.14 |
11:58 ET | 2800 | 12.205 |
12:00 ET | 2300 | 12.21 |
12:02 ET | 1663 | 12.28 |
12:03 ET | 10124 | 12.2 |
12:05 ET | 1421 | 12.07 |
12:07 ET | 530 | 12.08 |
12:09 ET | 4697 | 12.045 |
12:12 ET | 3744 | 12.0205 |
12:14 ET | 2845 | 12.015 |
12:16 ET | 2473 | 12 |
12:18 ET | 2553 | 12.04 |
12:20 ET | 522 | 12.08 |
12:21 ET | 485 | 12.16 |
12:23 ET | 1800 | 12.21 |
12:27 ET | 100 | 12.17 |
12:30 ET | 4204 | 12.28 |
12:32 ET | 1375 | 12.35 |
12:34 ET | 5103 | 12.17 |
12:36 ET | 1349 | 12.16 |
12:38 ET | 1128 | 12.127 |
12:39 ET | 950 | 12.17 |
12:41 ET | 1399 | 12.25 |
12:43 ET | 776 | 12.21 |
12:45 ET | 1000 | 12.15 |
12:48 ET | 4476 | 12.101 |
12:50 ET | 500 | 12.1101 |
12:52 ET | 800 | 12.2 |
12:56 ET | 1664 | 12.04 |
12:59 ET | 788 | 12.12 |
01:01 ET | 300 | 12.0567 |
01:06 ET | 100 | 12.08 |
01:08 ET | 200 | 12.08 |
01:10 ET | 790 | 12.12 |
01:12 ET | 164 | 12.115 |
01:15 ET | 1647 | 12.06 |
01:17 ET | 7800 | 12.1316 |
01:19 ET | 1600 | 12.24 |
01:21 ET | 1000 | 12.239 |
01:24 ET | 200 | 12.19 |
01:28 ET | 7800 | 12.2 |
01:30 ET | 700 | 12.1 |
01:32 ET | 200 | 12.08 |
01:33 ET | 4554 | 11.945 |
01:35 ET | 318 | 11.93 |
01:37 ET | 1500 | 11.9699 |
01:39 ET | 1738 | 11.9201 |
01:42 ET | 3231 | 12 |
01:46 ET | 900 | 12.05 |
01:48 ET | 500 | 12.04 |
01:51 ET | 500 | 12.01 |
01:55 ET | 2743 | 12.005 |
01:57 ET | 700 | 12.01 |
02:00 ET | 1600 | 12 |
02:04 ET | 3257 | 11.81 |
02:06 ET | 5411 | 11.6601 |
02:08 ET | 3556 | 11.6799 |
02:09 ET | 600 | 11.7201 |
02:11 ET | 1337 | 11.7058 |
02:13 ET | 6120 | 11.62 |
02:15 ET | 8387 | 11.58 |
02:18 ET | 5199 | 11.5145 |
02:20 ET | 2352 | 11.5356 |
02:22 ET | 4828 | 11.66 |
02:24 ET | 3552 | 11.79 |
02:26 ET | 1600 | 11.79 |
02:27 ET | 500 | 11.7825 |
02:29 ET | 4450 | 11.8396 |
02:31 ET | 203 | 11.85 |
02:36 ET | 7136 | 11.635 |
02:40 ET | 346 | 11.63 |
02:42 ET | 2400 | 11.58 |
02:44 ET | 4551 | 11.5 |
02:45 ET | 6948 | 11.5001 |
02:49 ET | 3340 | 11.57 |
02:51 ET | 1601 | 11.6 |
02:54 ET | 3341 | 11.5262 |
02:56 ET | 526 | 11.55 |
02:58 ET | 854 | 11.56 |
03:00 ET | 2628 | 11.4999 |
03:02 ET | 354 | 11.4406 |
03:03 ET | 4861 | 11.31 |
03:05 ET | 3261 | 11.25 |
03:07 ET | 23085 | 11.16 |
03:09 ET | 6403 | 11.32 |
03:12 ET | 13748 | 11.3201 |
03:14 ET | 655 | 11.34 |
03:16 ET | 800 | 11.395 |
03:18 ET | 1577 | 11.3494 |
03:20 ET | 1416 | 11.35 |
03:21 ET | 830 | 11.4 |
03:23 ET | 250 | 11.428 |
03:25 ET | 1550 | 11.41 |
03:27 ET | 1314 | 11.41 |
03:30 ET | 6814 | 11.47 |
03:32 ET | 100 | 11.49 |
03:34 ET | 500 | 11.4901 |
03:36 ET | 1925 | 11.59 |
03:38 ET | 1846 | 11.62 |
03:39 ET | 400 | 11.635 |
03:41 ET | 2191 | 11.6559 |
03:43 ET | 3238 | 11.65 |
03:45 ET | 1300 | 11.645 |
03:48 ET | 800 | 11.6133 |
03:50 ET | 14521 | 11.63 |
03:52 ET | 4747 | 11.605 |
03:54 ET | 13196 | 11.52 |
03:56 ET | 6844 | 11.54 |
03:57 ET | 6895 | 11.545 |
03:59 ET | 14859 | 11.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Candel Therapeutics Inc | 377.8M | -8.9x | --- |
Anavex Life Sciences Corp | 380.9M | -9.2x | --- |
Tourmaline Bio Inc | 384.7M | -2.8x | --- |
Fibrobiologics Inc | 386.1M | -12.4x | --- |
Nautilus Biotechnology Inc | 365.8M | -5.5x | --- |
Q32 Bio Inc | 370.2M | -1.2x | --- |
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $377.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.29 |
Book Value | $0.44 |
P/E Ratio | -8.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.